Drugs associated the most with retroperitoneal fibrosis: Assessment of the 2015-2020 Food and Drug Administration (FDA) pharmacovigilance database

Published on Jun 1, 2021in European Urology20.096
· DOI :10.1016/S0302-2838(21)01083-6
Nicolò Schifano4
Estimated H-index: 4
,
Paolo Capogrosso23
Estimated H-index: 23
+ 12 AuthorsHussain M. Alnajjar9
Estimated H-index: 9
Source
Abstract
References0
Newest
Cited By0
Newest
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.